The N-terminal 6-Myc tag and the C-terminal 3HA tags of Cin8 were previously described (
Hildebrandt et al., 2006). A PCR-generated strategy was used to replace
CDC55 open reading frame with SpHIS5 (
Delneri et al., 2000) using (f) 5′-TCGATTACGTCAATTAGGCTCTCTTCTATATTTTAGTTCAGATCCGCTAGGGATAACAGG-3′ and (r) 5′-TTTCAATTAAAACAGTAGTAGTATGTGGGGAAGATATGGGTCATCGATGAATTCGAGCTC-3′ primers and the pKT101 plasmid from EUROSCARF collection (
Sheff and Thorn, 2004) as a template. The C-terminal 13-Myc tag was constructed using the pKT233 plasmid from EUROSCARF collection (
Sheff and Thorn, 2004). The
13Myc and
ADH1 termination region were PCR-amplified from the pKT233 plasmid using (f) 5′-CGCGAGCGGCCGCCCCGGGTTAATTAACGGTGAAC-3′ and (R) 5′-GAGCGTCTAGACCCTAGCGGATCTGCCGGTAGAG-3′ primers and replacing the
NotI-
XbaI fragment of pTK47, creating pRM39. Then, the
PstI-
XbaI fragment was transferred from pRM39 to pTK49 (
Hildebrandt et al., 2006), creating pRM40. Finally, the
SalI-
XbaI fragment of
CIN8-13Myc was transferred to the pRS316 vector, resulting in pJKY1. The C-terminal 3GFP tag of Cin8 was constructed by PCR amplification of the 3GFP sequence using the pB1963 plasmid as a template [a gift from David Pellman's lab (
Buttery et al., 2007)] and the (f) 5′-TCAAGCGGCCGCTCCTGCAGCCCGGGGGATCCA-3′ and (r) 5′-ACCGCGGTGGCGGCCGCT-3′ primers. The PCR-amplified sequence was introduced into the C-terminal
NotI site of
CIN8 (
Hildebrandt et al., 2006). For genomic integration of
CIN8-3GFP,
CIN8-3GFP was subcloned into the pRS305 vector (
Sikorski and Hieter, 1989) and integrated into the
LEU2 locus. Plasmid containing the mutations of the five Cdc28 phosphorylation sites (
cin8-5A) in pTK49 (
Hildebrandt et al., 2006), pYLCIN8 1-5, was a gift from Gavin Sherlock (Cold Spring Harbor Laboratories, Cold Spring Harbor, NY). To construct
6Myc-
cin8-5A,
AatII-
Sph1 fragment of
cin8-5A sequence was transferred from the pYLCIN8 1-5 plasmid to pTK103 (
Hildebrandt et al., 2006). The separation between the Cdc28-kinase phosphorylation sites in the motor domain and the tail of Cin8 was done using the unique
PstI site within the
CIN8 sequence. The phosphomimic
cin8-3D mutations (D277, D285, D493) were generated by PCR site-directed mutagenesis (
Ko and Ma, 2005), the following primers were used: (f) 5′-ATGCAAGCTTTGTCGACGTTTTCGCCCCAGGTT-3′, (r) 5′-ATGCGGTCTCAATGACCTAGGGTCACTGTTCCTAGAATTACTCCTGGAACTACTAGC-3′, (f) 5′-ATGCGGTCTCATCATTAAATGATCTGGATCCTAAAGCTGCTCTATTAAGAAAAAGG-3′, (r) 5′-ATGCCTGCAGGTTTCTTCAGAAGTTACCTTTGCAGGATCGATAGTAGCAATTAGTGCGGTTTTCGT-3′. The pRM59 plasmid containing the
3HA-CDC14 coding sequence under the
PGAL1 promoter was constructed by PCR-amplifying the
3HA-CDC14 sequence from the p194 plasmid (a gift from Angelica Amon, MIT Cambridge, MA), using (f) 5′-CGTCGTCTAGACGCTTATAAAAAAAAAAAAAAAATGCG-3′ and (r) 5′-CGGTGAAGTTATTCCTAGGTACCAGG-3′ primers and sub-cloning into the
KpnI-
XbaI sites of p416-GAL1 (
Mumberg et al., 1994). For bacteria expression of Cin8 motor domain, first 590 residues of (CIN8-WT) and (cin8-3A) were PCR amplified and cloned into
NdeI and
SphI sites of modified pRSET-B plasmid that contain TEVEGFP–6HIS at the C-terminus, creating pAG26 and pJKY34, respectively. The following primers were used: (f) 5′-AGTCCATATGGTATGGCCAGAAAGTAACGTTGAG-3′, (r) 5′-CTCGAGGCGGCCGCGCGCATGCCTTGCATTTTTCGATGTCAAACTTTCAAT-3′.